The Absorbable Tissue Spacer market studied is anticipated to grow with a CAGR of nearly 4.9%, during the forecast period. Certain factors that are driving the market growth include increasing prevalence of cancer and advantages associated with tissue spacer.

Globally, cancer is one of the leading causes of death. The disease witnessed significant growth in the last few decades, and it is expected to grow rapidly over the forecast period. The World Health Organization (WHO) estimates the rate of cancer number to increase to 70% over the next two decades.

Additionally, the increased burden of several lifestyle disorders is also expected to drive the market, as biomarkers play a vital role in risk assessment, early diagnosis, and effective monitoring of treatment.

Key Market Trends

Hydrogel-based Spacers Hold Significant Share in the Global Absorbable Tissue Spacer Market

  • Hydrogel based tissue spacers have usage across many fields of cancer. Prostate-rectum hydrogel spacer application is a relatively safe technical procedure that is well tolerated and has a high technical success rate. Spacer application significantly reduces rectal radiation dose and results in long-term reductions in rectal toxicity, as well as improvements in bowel, urinary, and sexual quality of life.
  • Various recent clinical trial results have demonstrated that the prostate-rectum spacer application technique is safe and well tolerated, and that the space created significantly reduces rectal injury during radiation therapy, leading to long-term clinical benefits. A clinically significant reduction in radiation therapy complication rates leads to improved patient outcomes, reduced toxicity concerns, and hopefully overall cost reductions.



North America Dominates the Global Absorbable Tissue Spacer Market

As per the American Cancer Society, in 2018, the United States witnessed around 164,690 new cases of prostate cancer, causing over 26,430 deaths. About 60% of the total prostate cancer cases diagnosed are among men aged 65 years or older. In order to tackle such challenges, extensive research in the field of diagnostics has been undertaken.

The ease in the US government regulations and availability of funds from various organizations, like the National Institute of Health, has provided the potential for researchers to invest more in developing absorbable tissue spacers. Hence, owing to the aforementioned factors, the entire region is expected to hold the major share in the global absorbable tissue spacer market.

Competitive Landscape

The global Absorbable Tissue Spacer market is competitive and consists of a few major players. Companies like Biocomposites, Bioprotect Ltd., Boston Scientific, CR Bard, Palette Life Sciences., among others, hold a substantial market share in the market.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support